249 related articles for article (PubMed ID: 28371598)
1. Natural and Chemotherapy-Induced Clonal Evolution of Tumors.
Ibragimova MK; Tsyganov MM; Litviakov NV
Biochemistry (Mosc); 2017 Apr; 82(4):413-425. PubMed ID: 28371598
[TBL] [Abstract][Full Text] [Related]
2. Clonal evolution models of tumor heterogeneity.
Shlush LI; Hershkovitz D
Am Soc Clin Oncol Educ Book; 2015; ():e662-5. PubMed ID: 25993239
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic analysis of tumor clonality.
Teixeira MR; Heim S
Adv Cancer Res; 2011; 112():127-49. PubMed ID: 21925303
[TBL] [Abstract][Full Text] [Related]
5. Somatic clonal evolution: A selection-centric perspective.
Scott J; Marusyk A
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):139-150. PubMed ID: 28161395
[TBL] [Abstract][Full Text] [Related]
6. Clonal evolution and expansion associated with therapy resistance and relapse of colorectal cancer.
S A; Chakraborty A; Patnaik S
Mutat Res Rev Mutat Res; 2022; 790():108445. PubMed ID: 36371022
[TBL] [Abstract][Full Text] [Related]
7. Clonal evolution and tumor-initiating cells: New dimensions in cancer patient treatment.
Apostoli AJ; Ailles L
Crit Rev Clin Lab Sci; 2016; 53(1):40-51. PubMed ID: 26397062
[TBL] [Abstract][Full Text] [Related]
8. Clonal Evolution of Multiple Myeloma-Clinical and Diagnostic Implications.
Salomon-Perzyński A; Jamroziak K; Głodkowska-Mrówka E
Diagnostics (Basel); 2021 Aug; 11(9):. PubMed ID: 34573876
[TBL] [Abstract][Full Text] [Related]
9. Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study.
Kridel R; Chan FC; Mottok A; Boyle M; Farinha P; Tan K; Meissner B; Bashashati A; McPherson A; Roth A; Shumansky K; Yap D; Ben-Neriah S; Rosner J; Smith MA; Nielsen C; Giné E; Telenius A; Ennishi D; Mungall A; Moore R; Morin RD; Johnson NA; Sehn LH; Tousseyn T; Dogan A; Connors JM; Scott DW; Steidl C; Marra MA; Gascoyne RD; Shah SP
PLoS Med; 2016 Dec; 13(12):e1002197. PubMed ID: 27959929
[TBL] [Abstract][Full Text] [Related]
10. Patient-derived xenografts undergo mouse-specific tumor evolution.
Ben-David U; Ha G; Tseng YY; Greenwald NF; Oh C; Shih J; McFarland JM; Wong B; Boehm JS; Beroukhim R; Golub TR
Nat Genet; 2017 Nov; 49(11):1567-1575. PubMed ID: 28991255
[TBL] [Abstract][Full Text] [Related]
11. Intratumor diversity and clonal evolution in cancer--a skeptical standpoint.
Gisselsson D
Adv Cancer Res; 2011; 112():1-9. PubMed ID: 21925299
[TBL] [Abstract][Full Text] [Related]
12. Zebrafish as a model to assess cancer heterogeneity, progression and relapse.
Blackburn JS; Langenau DM
Dis Model Mech; 2014 Jul; 7(7):755-62. PubMed ID: 24973745
[TBL] [Abstract][Full Text] [Related]
13. Clonal evolution in cancer.
Greaves M; Maley CC
Nature; 2012 Jan; 481(7381):306-13. PubMed ID: 22258609
[TBL] [Abstract][Full Text] [Related]
14. Clonal interactions in cancer: Integrating quantitative models with experimental and clinical data.
Lee ND; Kaveh K; Bozic I
Semin Cancer Biol; 2023 Jul; 92():61-73. PubMed ID: 37023969
[TBL] [Abstract][Full Text] [Related]
15. The impact of intra-clonal heterogeneity on the treatment of multiple myeloma.
Brioli A; Melchor L; Cavo M; Morgan GJ
Br J Haematol; 2014 May; 165(4):441-54. PubMed ID: 24580032
[TBL] [Abstract][Full Text] [Related]
16. Cellular heterogeneity in malignant tumors. The importance of clonal interaction on tumor evolution, response to chemotherapy and metastatic ability evaluated in experimental systems.
Aabo K
Dan Med Bull; 1996 Sep; 43(4):336-49. PubMed ID: 8884135
[No Abstract] [Full Text] [Related]
17. Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design.
Diaz-Cano SJ
Int J Mol Sci; 2012; 13(2):1951-2011. PubMed ID: 22408433
[TBL] [Abstract][Full Text] [Related]
18. Spatial epitope barcoding reveals clonal tumor patch behaviors.
Rovira-Clavé X; Drainas AP; Jiang S; Bai Y; Baron M; Zhu B; Dallas AE; Lee MC; Chu TP; Holzem A; Ayyagari R; Bhattacharya D; McCaffrey EF; Greenwald NF; Markovic M; Coles GL; Angelo M; Bassik MC; Sage J; Nolan GP
Cancer Cell; 2022 Nov; 40(11):1423-1439.e11. PubMed ID: 36240778
[TBL] [Abstract][Full Text] [Related]
19. Evolution of intratumoral genetic heterogeneity during colorectal cancer progression.
Losi L; Baisse B; Bouzourene H; Benhattar J
Carcinogenesis; 2005 May; 26(5):916-22. PubMed ID: 15731168
[TBL] [Abstract][Full Text] [Related]
20. Genetic heterogeneity and clonal evolution in neuroblastoma.
Mora J; Cheung NK; Gerald WL
Br J Cancer; 2001 Jul; 85(2):182-9. PubMed ID: 11461074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
